Banco Bradesco S.A. filings document the foreign-issuer disclosures of a Brazilian financial institution whose American depositary shares represent preferred shares. The company furnishes Form 6-K reports covering IFRS consolidated financial statements, management analysis, loan portfolio composition, funding sources, loan-loss provisions, fee income, operating expenses, Basel indicators and economic perspectives.
The filing record also includes disclosures on Bradesco Seguros, digital and customer-service channels, international operations, and healthcare-asset consolidation involving Bradsaúde. Other reports cover CVM/B3 correspondence, material notices to the market, governance matters, controller and director securities transactions, and ownership information relevant to Bradesco's capital structure and ADR investors.
Banco Bradesco S.A. filed a Form 6-K summarizing April 2026 share positions and trades by its controlling group, management, family dependants, treasury and related companies. The controlling shareholders held 3,811,582,439 common shares and 121,067,106 non-voting shares, with opening and closing balances unchanged.
Most boards, committees, controlled and related companies reported no operations in securities or derivatives during the month. The Board of Executive Officers executed modest trades in non-voting shares, including purchases and sales totaling tens of thousands of shares, leading to a small reduction from 12,025,669 to 11,910,709 non-voting shares. Treasury stock remained at 10,650,000 common and 10,650,000 non-voting shares.
Banco Bradesco S.A. posted strong 1Q26 results, with recurring net income of R$6.8 billion, up 16.1% year over year and 4.5% versus 4Q25, supported by higher revenues and insurance earnings.
Total revenue reached R$36.9 billion, rising 14.0% year over year, while net interest income increased 16.4% to R$20.1 billion on larger loan volumes and slightly higher margins. The expanded loan portfolio grew 8.4% in 12 months to R$1.09 trillion, with a larger share of secured lending and growth in payroll-deductible loans, vehicle finance and working capital.
Asset quality remained broadly controlled: the over-90-day delinquency ratio was 4.2%, with pressure in MSMEs and legacy rural credit offset by declining restructured exposures. Credit costs rose, as expenses with expanded loan loss provisions climbed 26.5% year over year to R$9.7 billion, lifting the credit cost to 3.5%.
The insurance group delivered net income of R$2.8 billion, up 13.0% year over year, with a 21.6% ROAE and 20.4% growth in income from insurance, pension and capitalization operations. At the consolidated level, ROAE was 15.8% and Basel total capital ratio was 14.9%, with common equity at 10.2% as of March 2026. Management reaffirmed its transformation plan and guidance for 2026, targeting loan growth, higher net interest income after provisions and mid–single-digit fee growth.
Banco Bradesco S.A. reports first-quarter 2026 consolidated IFRS results, highlighting solid balance sheet growth amid a mixed Brazilian macroeconomic backdrop with high but easing interest rates and geopolitical uncertainties.
Total deposits reached R$752.2 billion, up 20.8% year over year, while the expanded loan portfolio grew 8.4% to R$1,089.9 billion, split between R$474.0 billion to individuals and R$615.9 billion to companies. Securities portfolios totaled R$888.5 billion, an increase of 12.2%.
Net income was R$5.2 billion, with earnings per share of R$0.47 for common shares and R$0.51 for preferred shares. Book value per share reached R$17.01 and Tier I capital was 12.0%, supported by a capital increase to R$93.77 billion. Allowance for expanded loans was R$56.9 billion, slightly higher year over year.
Bradesco advanced a corporate restructuring to consolidate its health business, including the partial split of Bradseg and integration of Odontoprev into a broader health ecosystem. The bank also emphasized continued investment in technology, artificial intelligence and digital channels, and reported reaching 89% of its R$450 billion sustainable finance target set for the period through 2026.
Banco Bradesco posted strong first-quarter 2026 results, with recurring net income of R$6.8 billion, up 4.5% versus the prior quarter and 16.1% year over year. Total revenue reached R$36.9 billion, an increase of 14.0% in 12 months, supported by higher net interest income, fees, and insurance income.
The expanded loan portfolio rose to R$1.09 trillion, up 8.4% year over year, with a growing share of secured lending such as payroll-deductible loans, auto financing and real estate. Asset quality remained broadly stable: loans over 90 days past due were 4.2%, only 0.1 percentage point higher than a year earlier.
Credit costs increased, with expenses from expanded loan loss provisions 26.5% higher than a year ago, reflecting specific wholesale cases and older rural credit vintages. Even so, return on average equity improved to 15.8%, while the cost-to-income ratio fell to 46.9%, showing better efficiency.
Banco Bradesco S.A. reports that the merger of shares issued by Bradesco Gestão de Saúde S.A. into Bradsaúde S.A. has been approved and completed, confirming the previously defined exchange ratio without adjustments. As a result, Bradesco’s equity interest in Bradsaúde increased to 91.35% of total and voting capital, not considering any potential exercises of withdrawal rights by dissenting Bradsaúde shareholders, whose term runs until May 7, 2026.
The company also notes that an extraordinary general meeting of Mediservice Operadora de Planos de Saúde S.A. is scheduled for May 1, 2026, to approve the contribution of Bradsaúde’s dental plans portfolio and other operational assets and liabilities to Mediservice, which became an indirect subsidiary of Bradsaúde after the merger of shares. Bradesco states it will continue to inform shareholders and the market of material developments.
BANK BRADESCO Executive Officer discloses existing shareholdings. Executive Officer Tulio Xavier de Oliveira filed an initial ownership report showing he directly holds 800,565 preference shares (BBDC4). This Form 3 records his current stake in the company’s preferred shares and does not reflect any newly reported purchase or sale.
BANK BRADESCO executive officer and CHRO Silvana Rosa Machado filed an initial statement of beneficial ownership. The filing reports direct ownership of 173,401 preference shares (BBDC4) following the reported position. This entry records her existing holdings rather than a new purchase or sale.
BANK BRADESCO director Rubens Aguiar Alvarez filed an initial ownership report showing holdings in the bank’s shares. He directly owns 217,731 preference shares (BBDC4) and is reported with indirect holdings of 214,984 preference shares BBDC4 and 30,250 common shares BBDC3 held by family members in the same household, with a disclaimer of beneficial ownership.
BANK BRADESCO director Rogerio Pedro Camara has filed an initial ownership statement showing a direct holding of 388,155 preference shares (BBDC4). These shares are reported as directly owned as of March 18, 2026, giving investors a view of his existing equity stake.
BANK BRADESCO Executive Officer Paris Roberto de Jesus has reported his existing equity position on a Form 3. He directly holds 321,127 preference shares (BBDC4) following the reported entry, and the filing records this as a holding rather than a new purchase or sale.